Finished Pharmaceutical
Formulations

Topical FormulationsSingle

Aceclofenac 1.5 %w/w + Linseed Oil 3% w/w + Methyl Salicylate 10 %w/w + Menthol 5%w/w + Capsaicin 0.025 %w/w + benzyl Alcohol 1w/w

Topical Formulation

Aceclofenac 1.5 %w/w + Linseed Oil 3% w/w + Methyl Salicylate 10 %w/w + Menthol 5%w/w + Capsaicin 0.025 %w/w + benzyl Alcohol 1w/w is a topical formulation formulated with Aceclofenac 1.5 %w/w + Linseed Oil 3% w/w + Methyl Salicylate 10 %w/w + Menthol 5%w

Available strengths

Aceclofenac 1.5 %w/w + Linseed Oil 3% w/w + Methyl Salicylate 10 %w/w + Menthol 5%w/w + Capsaicin 0.025 %w/w + benzyl Alcohol 1w/w

Topical FormulationsSingle

Adapalene BP 0.1% w/w

Topical Formulation

Adapalene BP 0.1% w/w is a topical formulation formulated with Adapalene BP 0.1% w/w. The listed active ingredient profile is Adapalene % w/w, placing the product in the acne / pigmentation dermatology category. The formulation contains dermatological ing

Available strengths

Adapalene BP 0.1% w/w

Topical FormulationsSingle

Adapalene BP 0.1%w/w Gel

Gel

Adapalene BP 0.1%w/w Gel is a gel formulated with Adapalene BP 0.1%w/w. The listed active ingredient profile is Adapalene w/w, placing the product in the acne / pigmentation dermatology category. The formulation contains dermatological ingredients used in

Available strengths

Adapalene BP 0.1%w/w

Topical FormulationsSingle

Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w

Topical Formulation

Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w is a topical formulation formulated with Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w. The listed active ingredient profile is Beclomehasone Dipropionate w/w; Salicylic Acid w/w, p

Available strengths

Beclomehasone Dipropionate 0.025%w/w + Salicylic Acid 3%w/w

Topical FormulationsSingle

Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w Ointment

Ointment

Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w Ointment is a ointment formulated with Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w. The listed active ingredient profile is Beclomenthasone Dipropionate w/w; S

Available strengths

Beclomenthasone Dipropionate USP 0.025%w/w + Salicylic Acid IP 37%w/w

Topical FormulationsSingle

Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w

Topical Formulation

Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w is a topical formulation formulated with Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w. The listed active ingredient profile is Beclomethasone Diprolplonate w/w; Clotrimazole l1%w/w

Available strengths

Beclomethasone Diprolplonate 0.02%w/w + Clotrimazole l1%w/w

Topical FormulationsSingle

Beclomethasone Dipropionate IP 0.0257%w/w Cream

Cream

Beclomethasone Dipropionate IP 0.0257%w/w Cream is a cream formulated with Beclomethasone Dipropionate IP 0.0257%w/w. The listed active ingredient profile is Beclomethasone Dipropionate w/w, placing the product in the topical anti-inflammatory / dermatolo

Available strengths

Beclomethasone Dipropionate IP 0.0257%w/w

Topical FormulationsSingle

Beclomethasone Diproplonate 0.025%wtw

Topical Formulation

Beclomethasone Diproplonate 0.025%wtw is a topical formulation formulated with Beclomethasone Diproplonate 0.025%wtw. The listed active ingredient profile is Beclomethasone Diproplonate wtw, placing the product in the topical anti-inflammatory / dermatolo

Available strengths

Beclomethasone Diproplonate 0.025%wtw

Topical FormulationsSingle

Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w

Topical Formulation

Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w is a topical formulation formulated with Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w. The listed active ingredient profile is Beclomethasone Diproplonate °; Ketoconazole % w/w

Available strengths

Beclomethasone Diproplonate 0.025°/0w/w + Ketoconazole 2% w/w

Topical FormulationsSingle

Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w Cream

Cream

Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w Cream is a cream formulated with Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w. The listed active ingredient profile is Beclomethgsone Dipropionate w/w; Ketoconazole w/w, placin

Available strengths

Beclomethgsone Dipropionate IP 0.025%w/w + Ketoconazole 2%w/w

Topical FormulationsSingle

Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg

Topical Formulation

Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg is a topical formulation formulated with Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg. The listed active ingredient profile is Betamethasone Dip

Available strengths

Betamethasone Dipropionate 0.25 mg + fusidic Acid 20 mg + Chlorocresol 1.2 mg

Topical FormulationsSingle

Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg

Topical Formulation

Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg is a topical formulation formulated with Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg. The listed active ingredient profile is Betamethasone Dipropionate; Salicylic Acid, placing the p

Available strengths

Betamethasone Dipropionate 0.64 mg + Salicylic Acid 30 mg

Topical FormulationsSingle

Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg

Topical Formulation

Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg is a topical formulation formulated with Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg. The listed active ingredient profile is Bet

Available strengths

Betamethasone Dipropionate IP 0.25 mg + Fusidic Acid IP 20 mg Chlorocresol lp 1.2 mg

Topical FormulationsSingle

Calamine 8%w/w*Light liquid Paraffin 10%w/w + Methylparaben 0.20%w/w + Propylparaben 0.02%w/W

Topical Formulation

Calamine 8%w/w*Light liquid Paraffin 10%w/w + Methylparaben 0.20%w/w + Propylparaben 0.02%w/W is a topical formulation formulated with Calamine 8%w/w*Light liquid Paraffin 10%w/w + Methylparaben 0.20%w/w + Propylparaben 0.02%w/W. The listed active ingredi

Available strengths

Calamine 8%w/w*Light liquid Paraffin 10%w/w + Methylparaben 0.20%w/w + Propylparaben 0.02%w/W

Topical FormulationsSingle

Calcium Dobesilate Monohydrate 0.5 % w/w + Lignocaine HCI. 3.0% w/w Hydrocortisone Acetate 0.25%w/w + Zinc Oxide 5.0%w/w + Chlorocresol 0.1%w/w

Topical Formulation

Calcium Dobesilate Monohydrate 0.5 % w/w + Lignocaine HCI. 3.0% w/w Hydrocortisone Acetate 0.25%w/w + Zinc Oxide 5.0%w/w + Chlorocresol 0.1%w/w is a topical formulation formulated with Calcium Dobesilate Monohydrate 0.5 % w/w + Lignocaine HCI. 3.0% w/w Hy

Available strengths

Calcium Dobesilate Monohydrate 0.5 % w/w + Lignocaine HCI. 3.0% w/w Hydrocortisone Acetate 0.25%w/w + Zinc Oxide 5.0%w/w + Chlorocresol 0.1%w/w

Topical FormulationsSingle

Choline Sallcylate BP 8.77w/w + Lignocaine Hcl IP 2%w/w Gel

Gel

Choline Sallcylate BP 8.77w/w + Lignocaine Hcl IP 2%w/w Gel is a gel formulated with Choline Sallcylate BP 8.77w/w + Lignocaine Hcl IP 2%w/w. The listed active ingredient profile is Choline Sallcylate; Lignocaine Hcl w/w, placing the product in the topica

Available strengths

Choline Sallcylate BP 8.77w/w + Lignocaine Hcl IP 2%w/w

Topical FormulationsSingle

Ciclopirox Olamine 1 %w/w

Topical Formulation

Ciclopirox Olamine 1 %w/w is a topical formulation formulated with Ciclopirox Olamine 1 %w/w. The listed active ingredient profile is Ciclopirox Olamine w/w, placing the product in the topical antifungal / dermatology category. The formulation contains to

Available strengths

Ciclopirox Olamine 1 %w/w

Topical FormulationsSingle

Ciprofloxacin HCI 1%w/w + Metronidazole Benzoate 1%w/wterbinafine HCI 1%w/w + Clobetasol Propionate 0.05%w/w

Topical Formulation

Ciprofloxacin HCI 1%w/w + Metronidazole Benzoate 1%w/wterbinafine HCI 1%w/w + Clobetasol Propionate 0.05%w/w is a topical formulation formulated with Ciprofloxacin HCI 1%w/w + Metronidazole Benzoate 1%w/wterbinafine HCI 1%w/w + Clobetasol Propionate 0.05%

Available strengths

Ciprofloxacin HCI 1%w/w + Metronidazole Benzoate 1%w/wterbinafine HCI 1%w/w + Clobetasol Propionate 0.05%w/w

Topical FormulationsSingle

Clindamycin Phosphate 1.00%w/w Sodium Methyparaban0.1%w/w Phenoxyehenol 0.25% w/w/

Topical Formulation

Clindamycin Phosphate 1.00%w/w Sodium Methyparaban0.1%w/w Phenoxyehenol 0.25% w/w/ is a topical formulation formulated with Clindamycin Phosphate 1.00%w/w Sodium Methyparaban0.1%w/w Phenoxyehenol 0.25% w/w/. The listed active ingredient profile is Clindam

Available strengths

Clindamycin Phosphate 1.00%w/w Sodium Methyparaban0.1%w/w Phenoxyehenol 0.25% w/w/

Topical FormulationsSingle

Clindamycin Phosphate 1%w/w + Sodium Propylparaben 0.056 % w/w Sodium Methylparaben 0.114%w/w

Topical Formulation

Clindamycin Phosphate 1%w/w + Sodium Propylparaben 0.056 % w/w Sodium Methylparaben 0.114%w/w is a topical formulation formulated with Clindamycin Phosphate 1%w/w + Sodium Propylparaben 0.056 % w/w Sodium Methylparaben 0.114%w/w. The listed active ingredi

Available strengths

Clindamycin Phosphate 1%w/w + Sodium Propylparaben 0.056 % w/w Sodium Methylparaben 0.114%w/w

Topical FormulationsSingle

Clindamycin Phosphate Eq. to Clindamycin 1%w/w + Nicotinamide 4%w/w

Topical Formulation

Clindamycin Phosphate Eq. to Clindamycin 1%w/w + Nicotinamide 4%w/w is a topical formulation formulated with Clindamycin Phosphate Eq. to Clindamycin 1%w/w + Nicotinamide 4%w/w. The listed active ingredient profile is Clindamycin Phosphate . Clindamycin w

Available strengths

Clindamycin Phosphate Eq. to Clindamycin 1%w/w + Nicotinamide 4%w/w

Topical FormulationsSingle

Clindamycin Phosphate IP 1.007%w/w + Adapalene BP 0.1% w/w*Preservative : Sodium Methylpargben IP 0.1%w/w + Phenoxyehenol IP 0.25%w/w Gel

Gel

Clindamycin Phosphate IP 1.007%w/w + Adapalene BP 0.1% w/w*Preservative : Sodium Methylpargben IP 0.1%w/w + Phenoxyehenol IP 0.25%w/w Gel is a gel formulated with Clindamycin Phosphate IP 1.007%w/w + Adapalene BP 0.1% w/w*Preservative : Sodium Methylpargb

Available strengths

Clindamycin Phosphate IP 1.007%w/w + Adapalene BP 0.1% w/w*Preservative : Sodium Methylpargben IP 0.1%w/w + Phenoxyehenol IP 0.25%w/w

Topical FormulationsSingle

Clobetasol Propionate 0.05%%w/w + Salicylic Acld 3.0%w/w

Topical Formulation

Clobetasol Propionate 0.05%%w/w + Salicylic Acld 3.0%w/w is a topical formulation formulated with Clobetasol Propionate 0.05%%w/w + Salicylic Acld 3.0%w/w. The listed active ingredient profile is Clobetasol Propionate %%w/w; Salicylic Acld w/w, placing th

Available strengths

Clobetasol Propionate 0.05%%w/w + Salicylic Acld 3.0%w/w

Topical FormulationsSingle

Clobetasol Propionate 0.05%w/w

Topical Formulation

Clobetasol Propionate 0.05%w/w is a topical formulation formulated with Clobetasol Propionate 0.05%w/w. The listed active ingredient profile is Clobetasol Propionate w/w, placing the product in the topical anti-inflammatory / dermatology category. The for

Available strengths

Clobetasol Propionate 0.05%w/w

Topical FormulationsSingle

Clobetasol Propionate 0.05%w/w + Neomycin 0.5%w/w Miconazole Nitrate 2.7% w/w

Topical Formulation

Clobetasol Propionate 0.05%w/w + Neomycin 0.5%w/w Miconazole Nitrate 2.7% w/w is a topical formulation formulated with Clobetasol Propionate 0.05%w/w + Neomycin 0.5%w/w Miconazole Nitrate 2.7% w/w. The listed active ingredient profile is Clobetasol Propio

Available strengths

Clobetasol Propionate 0.05%w/w + Neomycin 0.5%w/w Miconazole Nitrate 2.7% w/w